Cargando…

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist

Nebivolol, a third generation β-adrenoceptor (β-AR) antagonist (β-blocker), causes vasodilation by inducing nitric oxide (NO) production. The mechanism via which nebivolol induces NO production remains unknown, resulting in the genesis of much of the controversy regarding the pharmacological action...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erickson, Catherine E., Gul, Rukhsana, Blessing, Christopher P., Nguyen, Jenny, Liu, Tammy, Pulakat, Lakshmi, Bastepe, Murat, Jackson, Edwin K., Andresen, Bradley T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748024/ https://www.ncbi.nlm.nih.gov/pubmed/23977191 http://dx.doi.org/10.1371/journal.pone.0071980

Ejemplares similares

Regulation of cardiac miR-208a, an inducer of obesity, by Rapamycin and Nebivolol
por: Gul, Rukhsana, et al.
Publicado: (2015)

ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins
por: Matti, Christoph, et al.
Publicado: (2020)

Differential Effects of β-Blockers, Angiotensin II Receptor Blockers, and a Novel AT2R Agonist NP-6A4 on Stress Response of Nutrient-Starved Cardiovascular Cells
por: Mahmood, Abuzar, et al.
Publicado: (2015)

CXCR7: a β-arrestin-biased receptor that potentiates cell migration and recruits β-arrestin2 exclusively through Gβγ subunits and GRK2
por: Nguyen, Huong Thi, et al.
Publicado: (2020)

Double life: How GRK2 and β-arrestin signaling participate in diseases
por: Zhai, Ruxu, et al.
Publicado: (2022)

Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias
por: Kawakami, Kouki, et al.
Publicado: (2022)

β-Arrestin–Biased Angiotensin II Receptor Agonists for COVID-19
por: Manglik, Aashish, et al.
Publicado: (2020)

Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases
por: Liu, Haiping, et al.
Publicado: (2023)

Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist
por: Doi, Seira, et al.
Publicado: (2016)

Biased β-Agonists Favoring Gs over β-Arrestin for Individualized Treatment of Obstructive Lung Disease
por: Tokmakova, Alina, et al.
Publicado: (2022)

Determining the Effects of Differential Expression of GRKs and β-arrestins on CLR-RAMP Agonist Bias
por: Pearce, Abigail, et al.
Publicado: (2022)

The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury
por: Nurlu Temel, Esra, et al.
Publicado: (2023)

Isoprenaline and salbutamol inhibit pyroptosis and promote mitochondrial biogenesis in arthritic chondrocytes by downregulating β-arrestin and GRK2
por: Ajmal, Iqra, et al.
Publicado: (2022)

Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor
por: Burghi, Valeria, et al.
Publicado: (2023)

Unique Positive Cooperativity Between the β-Arrestin–Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor
por: Pani, Biswaranjan, et al.
Publicado: (2021)

Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats
por: Nascimento, Mariana Moura, et al.
Publicado: (2022)

Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells
por: Møller, Thor C., et al.
Publicado: (2020)

Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT(1) receptor with protective action in cardiac hypertrophy
por: Teixeira, Larissa B., et al.
Publicado: (2017)

Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT(2A) Receptor Agonists
por: Poulie, Christian B. M., et al.
Publicado: (2022)

Disentangling bias between G(q), GRK2, and arrestin3 recruitment to the M(3) muscarinic acetylcholine receptor
por: Flöser, Anja, et al.
Publicado: (2021)

Regulation of Constitutive GPR3 Signaling and Surface Localization by GRK2 and β-arrestin-2 Overexpression in HEK293 Cells
por: Lowther, Katie M., et al.
Publicado: (2013)

Molecular mechanisms of fentanyl mediated β-arrestin biased signaling
por: de Waal, Parker W., et al.
Publicado: (2020)

β-Arrestin2-biased Drd2 agonist UNC9995 alleviates astrocyte inflammatory injury via interaction between β-arrestin2 and STAT3 in mouse model of depression
por: Liu, Yang, et al.
Publicado: (2022)

Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors
por: Jones, Ben, et al.
Publicado: (2020)

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2016)

Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
por: McCorvy, John D., et al.
Publicado: (2017)

Comparative analyses of downstream signal transduction targets modulated after activation of the AT(1) receptor by two β-arrestin-biased agonists
por: Santos, Geisa A., et al.
Publicado: (2015)

Protective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats
por: Atwa, Ahmed, et al.
Publicado: (2017)

Correction: Nebivolol, a β(1)-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2017)

Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease
por: AlHabeeb, Waleed, et al.
Publicado: (2021)

β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study
por: Lashen, Sameh A, et al.
Publicado: (2022)

Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
por: Weiss, Robert
Publicado: (2006)

Enhanced BRET Technology for the Monitoring of Agonist-Induced and Agonist-Independent Interactions between GPCRs and β-Arrestins
por: Kocan, Martina, et al.
Publicado: (2011)

Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors
por: Pandey, Shubhi, et al.
Publicado: (2021)

CXCR7 ameliorates myocardial infarction as a β-arrestin-biased receptor
por: Ishizuka, Masato, et al.
Publicado: (2021)

Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling
por: Grisanti, Laurel A., et al.
Publicado: (2018)

LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1
por: Rodriguiz, Ramona M., et al.
Publicado: (2021)

Impaired Recruitment of Grk6 and β-Arrestin2 Causes Delayed Internalization and Desensitization of a WHIM Syndrome-Associated CXCR4 Mutant Receptor
por: McCormick, Peter J., et al.
Publicado: (2009)

Cardiac Insulin Resistance and MicroRNA Modulators
por: Pulakat, Lakshmi, et al.
Publicado: (2012)

Protective Effects of Vasodilatory Βeta-Blockers Carvedilol and Nebivolol against Glycerol Model of Rhabdomyolysis-Induced Acute Renal Failure in Rats
por: Atwa, Ahmed, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_73l221vdkdlt9b4nucaim1tsb8